Authorised Therapeutic exploratory (Phase II) healthy individuals

The effect of CBD on sleep quality following late evening exercise

EU CTIS ID: 2024-518609-17-00

What this study is testing

To investigate the effect of CBD on sleep efficiency (SE = time asleep (min) / time in bed (min)) following late evening exercise

  • Therapeutic exploratory (Phase II)

A plain-language read of the study's public EU CTIS listing. The study team confirms the details.

Who can take part

You may be able to join if

  • Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures
  • Use of highly effective methods of birth control; defined as those that, alone or in combination, result in low failure rate (i.e., less than 1% per year) when used consistently and correctly; such as implants, injectables, combined oral contraceptives, some IUDs, true sexual abstinence (i.e. refraining from heterosexual intercourse during the entire period of risk associated with the Trial treatment(s)) or commitment to a vasectomised partner.
  • Age between 18-40 years old at the time of signing the Informed Consent Form (ICF)
  • Recreationally active (between 2-8h/wk)
  • Good health status confirmed by a sport medical screening
  • Body fat percentage below 20% (males) or 30% (females) as estimated by a Dual-energy X-ray absorptiometry (DXA) scan

You likely can't join if

  • Self-reported sleep disturbances
  • Habitual smoking (> 1 occasion/month)
  • Any kind of injury/incapability that is a contra-indication to perform high-intensity interval training
  • Female who is pregnant, breast-feeding or intends to become pregnant or is of child-bearing potential and not using an adequate, highly effective contraceptive
  • Participation in another interventional Trial with an investigational medicinal product (IMP) or device
  • Use of CBD related products 3 months prior to the start of the experimental trial (including CBD oil, cannabis or other substances containing cannabinoids)
See the full eligibility criteria
Who can join
  • Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures
  • Use of highly effective methods of birth control; defined as those that, alone or in combination, result in low failure rate (i.e., less than 1% per year) when used consistently and correctly; such as implants, injectables, combined oral contraceptives, some IUDs, true sexual abstinence (i.e. refraining from heterosexual intercourse during the entire period of risk associated with the Trial treatment(s)) or commitment to a vasectomised partner.
  • Age between 18-40 years old at the time of signing the Informed Consent Form (ICF)
  • Recreationally active (between 2-8h/wk)
  • Good health status confirmed by a sport medical screening
  • Body fat percentage below 20% (males) or 30% (females) as estimated by a Dual-energy X-ray absorptiometry (DXA) scan
  • Good sleep efficiency determined by the Pittsburgh Sleep Quality Index (PSQI, score ≤ 4)
What rules you out
  • Self-reported sleep disturbances
  • Habitual smoking (> 1 occasion/month)
  • Any kind of injury/incapability that is a contra-indication to perform high-intensity interval training
  • Female who is pregnant, breast-feeding or intends to become pregnant or is of child-bearing potential and not using an adequate, highly effective contraceptive
  • Participation in another interventional Trial with an investigational medicinal product (IMP) or device
  • Use of CBD related products 3 months prior to the start of the experimental trial (including CBD oil, cannabis or other substances containing cannabinoids)
  • Intake of any medication or nutritional supplement that influences sleep quality 3 months prior to the start of the experimental trial
  • Shift workers or extreme morning and evening chronotypes (scores between 16-30 or 70-86 on the Morningness-Eveningness Questionnaire (MEQ))

The study team makes the final eligibility decision.

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18-64 years. The study team makes the final eligibility decision.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.